: Stock price quadrupled (over 300% gain) following its expansion into CBD products and strategic supply deals. Biopharmaceutical & Industrial Stocks to Watch
: Skyrocketed more than 450% in 2017. Originally a produce grower, it pivoted to cannabis and hemp production, delivering the year's highest gains among major sector players. hemp stocks to buy 2017
: Rose 247% , largely fueled by a landmark $245 million investment from Constellation Brands. : Stock price quadrupled (over 300% gain) following
: Rallied 344% over the year, driven by a move to the larger TSX exchange and international supply agreements in Germany. Aphria : Gained 292% as a major Canadian medical producer. hemp stocks to buy 2017